Approaches for Direct Reduction of the Immunosuppressive HBs Antigen: Current Status & Outlook

Time: 12:00 pm
day: Day One


• Emerging clinical data points towards the need for both reduction of HBsAg levels alongside immunostimulation in order to achieve functional cure of CHB

• A limited number of modalities and mechanisms which directly lower HBsAg have been demonstrated preclinically and clinically

• Reviewing these mechanisms and considering how they may be used as part of a regimen to deliver functional cure